Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Return on Sales (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Return on Sales for 11 consecutive years, with 11.43% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 842.0% year-over-year to 11.43%, compared with a TTM value of 11.43% through Dec 2025, down 842.0%, and an annual FY2025 reading of 4.78%, down 389.0% over the prior year.
  • Return on Sales was 11.43% for Q4 2025 at Wave Life Sciences, down from 6.82% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.15% in Q3 2023 and bottomed at 136.86% in Q3 2022.
  • Average Return on Sales over 5 years is 19.45%, with a median of 5.46% recorded in 2025.
  • The sharpest move saw Return on Sales tumbled -13669bps in 2022, then skyrocketed 13700bps in 2023.
  • Year by year, Return on Sales stood at 19.71% in 2021, then crashed by -79bps to 35.28% in 2022, then soared by 98bps to 0.56% in 2023, then plummeted by -437bps to 3.01% in 2024, then tumbled by -280bps to 11.43% in 2025.
  • Business Quant data shows Return on Sales for WVE at 11.43% in Q4 2025, 6.82% in Q3 2025, and 5.8% in Q2 2025.